Brief: Annexon Submits Tanruprubart Marketing Authorization Application To The European Medicines Agency For Guillain-Barré Syndrome
08/01/2026 13:34
Jan 8 (Reuters) - Annexon Inc ANNX.O: ANNEXON SUBMITS TANRUPRUBART MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR GUILLAIN-BARRÉ SYNDROME ANNEXON INC: BLA SUBMISSION WITH U.S./EUROPEAN DATA FROM FORWARD TRIAL PLANNED IN 2026 Source text: ID:nGNX7prn4K Further company coverage: ANNX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annexon
See all newsBrief: Annexon Reports Inducement Grants to New Employees
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Annexon, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte